Intra-articular sodium hyaluronate injection for osteoarthritis treatment. Improves joint lubrication, reduces inflammation, and promotes tissue regeneration in arthritic joints.
Manufactured by
ZHEJIANG JINGJIA MEDICAL TECHNOLOGY CO., LTD
China
Founded in 1995, Zhejiang Jingjia is a National High-Tech Enterprise and a leader in Class III medical devices. We are the first Chinese company to secure CE certification for implantable Sodium Hyaluronate Gel. Certifications: CE, ISO 13485, ISO 9001, and MDSAP. Product Range: Anti-adhesion gels, OVDs, Intra-articular injections (CE), and Dermal fillers. Global Presence: 20+ years of OEM expertise for EU and Asian markets, exported to 30+ countries.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Hebei Houde Hanfang Medical Devices Group Co., Ltd.
China · 2 relevant products
Biosan Biyoteknoloji San ve Dış Tic A.Ş
Türkiye · 2 relevant products
Futerman International Products Laboratory
Argentina · 3 relevant products
22 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 50 closest product alternatives
Hebei Houde Hanfang Medical Devices Group Co., Ltd. · China
Therapeutic patch formulated for arthritis pain management and joint inflammation reduction. Applied topically for sustained therapeutic delivery to affected areas.
Biosan Biyoteknoloji San ve Dış Tic A.Ş · Türkiye
Pre-filled injection device delivering highly purified hyaluronic acid for intra-articular administration in joint disorders, particularly knee osteoarthritis. Each injection provides therapeutic hyaluronic acid composed of D-glucuronic acid and N-acetyl glucosamine disaccharide units to address cartilage degeneration and joint inflammation.
Futerman International Products Laboratory · Argentina
Cross-linked hyaluronic acid formulations for intra-articular injection in joint treatment and osteoarthritis management. Provides viscosupplementation and lubrication for damaged joints.
47 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products